Skip to main content
logo
Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
6.00
-0.04 (-0.66%)
Apr 21, 2026, 4:00 PM EDT - Market closed

Valneva SE Revenue

In the year 2025, Valneva SE had annual revenue of 174.66M EUR with 3.00% growth. Valneva SE had revenue of 47.69M in the quarter ending December 31, 2025, a decrease of -9.92%.

Revenue (ttm)
174.66M EUR
Revenue Growth
+3.00%
P/S Ratio
2.61
Revenue / Employee
259,136 EUR
Employees
674
Market Cap
535.43M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025174.66M5.08M3.00%
Dec 31, 2024169.58M15.87M10.32%
Dec 31, 2023153.71M-207.59M-57.46%
Dec 31, 2022361.30M13.22M3.80%
Dec 31, 2021348.09M237.76M215.52%
Dec 31, 2020110.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sutro Biopharma102.48M
4D Molecular Therapeutics85.21M
ADC Therapeutics81.36M
Fulcrum Therapeutics80.00M
Upstream Bio2.85M
Absci2.80M
Revenue Rankings

VALN News

More News